Nequita Dowling, MD
Family Medicine · Newport News, VANPI 1932308095
Payments from drug & device makers
Across 68 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$215
- Boehringer Ingelheim$122
- AbbVie$104
- GSK$102
- Pfizer$70
- Amgen$63
- plus $387 from 15 others
What the payments were for
- Food & beverage$1,03597%
- Education$283%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $215 |
| Boehringer Ingelheim | 8 | $122 |
| AbbVie | 4 | $104 |
| GSK | 6 | $102 |
| Pfizer | 5 | $70 |
| Amgen | 4 | $63 |
| Merck | 4 | $50 |
| Lilly USA, LLC | 3 | $45 |
| Novo Nordisk | 3 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Novartis | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $24 |
| Exact Sciences | 1 | $23 |
| Johnson & Johnson | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $12 |
| Mylan Specialty L.p. | 1 | $11 |
How this compares
$1,063 in reported general payments places this provider in the 65th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 18 | $1,243 |
| Duloxetine Hcl | 21 | $316 |
| Metoprolol Succinate | 27 | $281 |
| Atorvastatin Calcium | 16 | $237 |
| Sildenafil Citrate | 13 | $229 |
| Losartan Potassium | 37 | $228 |
| Amlodipine Besylate | 31 | $210 |
| Tizanidine Hcl | 11 | $134 |
| Levothyroxine Sodium | 20 | $117 |
| Pravastatin Sodium | 12 | $108 |
| Meloxicam | 12 | $20 |
| Hydrochlorothiazide | 13 | $4 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Newport News
- Chester FisherNewport News$146K
- David RosenbergNewport News$42K
- Thomas RobesonNewport News$34K
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.